AMO (Advanced Medical Optics) closes Pfizer deal:
This article was originally published in Clinica
Advanced Medical Optics (AMO) has completed the purchase of Pfizer's ophthalmic surgical business. Santa Ana, California-based AMO had agreed at the end of April this year to acquire the Pfizer unit in a $450m all-cash transaction (see Clinica No 1105, p 19). Through this deal, AMO's portfolio will be significantly boosted with the addition of Pfizer's CeeOn and Tecnis lines of intraocular lenses, its Healon family of viscoelastic products and the Baerveldt glaucoma shunt.
You may also be interested in...
CEO breaks down to Scrip how the Hong Kong-based company managed its way through the coronavirus outbreak in China, saying improvisation was critical.
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.